Recent Research Analysts’ Ratings Updates for Inspire Medical Systems (INSP)

Several brokerages have updated their recommendations and price targets on shares of Inspire Medical Systems (NYSE: INSP) in the last few weeks:

• 10/14/2026 – Inspire Medical Systems had its price target raised by Truist Financial Corporation from $62.00 to $78.00. They now have a “hold” rating on the stock.
• 10/13/2026 – Inspire Medical Systems was given a new $75.00 price target by Mizuho.
• 10/6/2026 – Inspire Medical Systems is now covered by Barclays PLC. They set an “underweight” rating and a $65.00 price target on the stock.
• 10/6/2026 – Inspire Medical Systems was upgraded by Barclays PLC to “strong sell”.
• 10/1/2026 – Inspire Medical Systems had its price target raised by Royal Bank Of Canada from $60.00 to $75.00. They now have a “sector perform” rating on the stock.
• 9/22/2026 – Inspire Medical Systems was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
• 9/22/2026 – Inspire Medical Systems was downgraded by Zacks Research from “strong-buy” to “hold”.
• 9/11/2026 – Inspire Medical Systems had its price target raised by Stifel Nicolaus from $75.00 to $80.00. They now have a “buy” rating on the stock.
• 9/4/2026 – Inspire Medical Systems was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”.
• 8/19/2026 – Inspire Medical Systems was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
• 8/17/2026 – Inspire Medical Systems was upgraded by Zacks Research from “hold” to “strong-buy”.

Insiders Place Their Bets

In other news, insider Jason Kelly sold 963 shares of the company’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $59.55, for a total transaction of $57,346.65. Following the sale, the insider directly owned 18,985 shares in the company, valued at $1,130,556.75. This represents a 4.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 2.20% of the stock is owned by insiders.

Inspire Medical Systems, Inc is a medical technology company focused on developing and commercializing treatments for obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company’s primary product is the Inspire therapy system, an implantable device designed for certain adults with moderate to severe OSA who are unable to use or obtain consistent benefits from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses an implantable pulse generator, a stimulation lead and a sensing lead.